The International oncology magazine Cancer World, published by the European School of Oncology, has just announced two initiatives to promote high-quality journalism on such a delicate and complex issue as cancer: up to 12 travel grants to attend a relevant conference in Amsterdam, and four journalism awards.
Theawards will go to «outstanding pieces of journalism published in 2015 and 2016 that are changing the way we think about cancer».
Journalists are invited to submit one or more items of their work – whether in print, online, on radio, video or television – into the following categories:
- Patient and carer experience
- Research, science and treatment
- Policy, services and affordability
A prize of €1500 is available in each category. The journalist judged the overall winner will also be funded to attend the ECCO Congress in Amsterdam (27-30 January 2017), where he/she will be presented with their award and take part in the Cancer World journalists’ professional development programme.
Applications are now open and can be made online
The closing date for entries for the Cancer World Journalism Award is 31st October 2016.
Cancer World and ESO also invite selected journalists to attennd European Cancer Congress (ECCO2017) will take place in Amsterdam, from 27-30 January 2017, with the theme “From evidence to practice in multidisciplinary cancer care”
«This is an opportunity to meet some of the leading thinkers and clinicians in cancer treatment and care across Europe, to make contacts, hone skills and gather some great story ideas. This is a very practical congress focused on issues of greatest concern to patients and professionals and should be of great help to any journalist interested in reporting on cancer – which remains a challenge for good journalism.
«The congress will address a number of important issues for the future of cancer care in Europe. As a multidisciplinary congress it brings together doctors, nurses, psychologists, patient advocates, policy makers and industry. The main focus will be a critical evaluation of new and recently presented clinical research data, and whether it will change clinical practice. It will look in particular at the evidence from Phase III trials and review clinical benefits and costs. There will be a focus on immunotherapy and personalised medicine, policy issues, evolving health care systems and disparities in cancer care.
The deadline for applying for the travel grants to attend the Amsterdam ECCO Conference is 11 November 2016.